Sentence examples for most likely progress from inspiring English sources

It is hard to know exactly what to make of this, albeit the big data approach to football analysis would suggest a clear and actionable trend: if Chelsea want to keep a clean sheet against Atlético Madrid and therefore most likely progress to the final of the Champions League, they need only pick their bearded enforcer and all-round lucky charm and the job is pretty much done.

The researchers utilized a mix of cognitive and neuropsychological assessments to better predict which participants had MCI and would most likely progress to AD.

Identifying individuals whose glucose tolerance will most likely progress over the years to dysglycemia would be of great public health benefit.

The ability to use biochemical markers to predict disease progression and identify patients most likely to progress is a top priority in the future management of OA.

Only a subset of patients who enter stage 3 chronic kidney disease (CKD) progress to stage 4. Identifying which patients entering stage 3 are most likely to progress could improve outcomes, by allowing more appropriate referrals for specialist care, and spare those unlikely to progress the adverse effects and costliness of an unnecessarily aggressive approach.

Efforts at earlier detection of AD face significant challenges in improving assessment of the earliest cognitive and neuropathological changes associated with early AD, identifying those MCI cases that are most likely to progress over time, and gauging the progression of MCI to a clinical diagnosis of AD.

A genetic test for prostate cancer could lead to more precise use of the prostate specific antigen, or P.S.A., test by identifying those men in whom the cancer is most likely to progress fastest.

The models show that larger length-to-width ratios with overlapping faults are least likely to form basin-crossing faults, and pull-apart basins with this geometry are thus most likely to progress to continental rupture.

The aim of this study was to use a case-control design to define the clinical and laboratory parameters that predict which patients with Clostridium difficile infection are most likely to progress to FCDC.

Here we discuss general considerations for a risk-targeted test-and-treat strategy based on a highly specific transcriptomic biomarker that can identify individuals who are most likely to progress to active TB disease as well as individuals with TB disease who have not yet presented for medical care.

This scenario reinforce the requirement for objective molecular biological markers of the aggressive phenotype to resolve uncertainties with respect to identification of those precursor lesions which are most likely to progress to invasive and metastatic prostate cancer.